SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-022228
Filing Date
2022-02-14
Accepted
2022-02-14 12:39:59
Documents
2
Group Members
BRIAN D. GROSSMANPARTNER ASSET MANAGEMENT, LLCPFM HEALTH SCIENCES GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm225765d5_sc13g.htm SC 13G/A 106402
2 JOINT FILING AGREEMENT tm225765d5_ex99-1.htm EX-99.1 6553
  Complete submission text file 0001104659-22-022228.txt   114738
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Subject) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87680 | Film No.: 22628225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 475 SANSOME STREET SUITE 1720 SAN FRANCISCO CA 94111
Business Address 475 SANSOME STREET SUITE 1720 SAN FRANCISCO CA 94111 415-281-1022
PFM Health Sciences, LP (Filed by) CIK: 0001442756 (see all company filings)

IRS No.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A